Trials / Sponsors / Wuhan Institute of Biological Products Co., Ltd
Wuhan Institute of Biological Products Co., Ltd
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Clinical Study of F61 Injection in Healthy Chinese Subjects COVID-19 | Phase 1 | 2022-08-01 |
| Unknown | A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19 COVID-19 | Phase 2 | 2022-05-01 |
| Unknown | To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years Influenza | Phase 4 | 2022-03-02 |